Stereotaxis (STXS) Cash from Investing Activities Growth (3y) (2014 - 2026)
Stereotaxis (STXS) Cash from Investing Activities Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | -26.99% |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | 15.82% |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | -12.04% |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | - |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | -27.34% |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | 19.27% |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | -5.81% |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | -3.15% |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | -35.55% |
| 10 | Stereotaxis | 128.56 Mn | 113.94 Mn | 3.79 Mn | 39.06% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 39.06% |
| Dec 31, 2025 | 84.84% |
| Dec 31, 2024 | 88.13% |
| Sep 30, 2024 | 57.70% |
| Dec 31, 2022 | -1,037.29% |
| Sep 30, 2022 | -224.51% |
| Mar 31, 2022 | -389.60% |
| Dec 31, 2021 | -393.88% |
| Sep 30, 2021 | 36.45% |
| Jun 30, 2021 | -35.26% |
| Mar 31, 2021 | -50.42% |
| Dec 31, 2018 | 52.63% |
| Sep 30, 2018 | -200.01% |
| Mar 31, 2018 | 42.45% |
| Dec 31, 2017 | 50.07% |
| Sep 30, 2017 | -118.48% |
| Dec 31, 2015 | -439.11% |
| Sep 30, 2015 | 24.46% |
| Mar 31, 2015 | 13.96% |
| Dec 31, 2014 | -9.02% |